Correction to: Reviews in Endocrine and Metabolic Disorders (2018) 19:363–395

https://doi.org/10.1007/s11154-018-9478-8

The authors would like to note that several errors had occurred, especially in Table 2, Tables 5, 6 and 7, Figure 13, and in the legend of Figure 23.

Table 7 Effect of the lipid-lowering drug simvastatin on the frequency of proinflammatory Interferon-gamma+ and regulatory IL-10+ thyroid-autoreactive CD4+ T helper cells in patients with autoimmune thyroiditis in comparison to untreated patients and healthy donors
Full size table
Fig. 13
figure 1

Statins as immunomodulatory therapy in GO

Full size image

On page 365, right column, bottom, and on page 366, left column, top, the sentence should read “….role in the pathogenesis of autoimmune thyroid disease, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, and others.”

On page 368, Table 2, left column, under the heading “Criterion” the following typographical errors should be corrected to the vertical column:

  • Increased frequency…..

  • Increased responsiveness of IL-10…

  • Enhancements of upregulated…

On page 371, in Figure 13 the blue cell “Th” should be corrected to “Th1”.

On page 375, right column, middle section, the sentence should read “…in Table 8 revealed a statin-induced….

On page 386, the legend of Figure 23 at the end of the page should be corrected to “…whereas few unbalanced IL-17+IFN-gamma+ Th17/Th1 cells responding to peptide 9 were found….

On page 375 in Table 5 and on page 388 in Table 6 “Mal. weight” should be corrected to “Mol. weight”.

On page 389, in Table 7 the horizontal line under “Group” should be corrected as well as the table legend, see reprinted Table 7.